Correlation Between Enliven Therapeutics and INmune Bio
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and INmune Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and INmune Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and INmune Bio, you can compare the effects of market volatilities on Enliven Therapeutics and INmune Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of INmune Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and INmune Bio.
Diversification Opportunities for Enliven Therapeutics and INmune Bio
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Enliven and INmune is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and INmune Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INmune Bio and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with INmune Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INmune Bio has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and INmune Bio go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and INmune Bio
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 0.83 times more return on investment than INmune Bio. However, Enliven Therapeutics is 1.2 times less risky than INmune Bio. It trades about 0.06 of its potential returns per unit of risk. INmune Bio is currently generating about -0.06 per unit of risk. If you would invest 1,830 in Enliven Therapeutics on September 3, 2024 and sell it today you would earn a total of 608.00 from holding Enliven Therapeutics or generate 33.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. INmune Bio
Performance |
| Timeline |
| Enliven Therapeutics |
| INmune Bio |
Enliven Therapeutics and INmune Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and INmune Bio
The main advantage of trading using opposite Enliven Therapeutics and INmune Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, INmune Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INmune Bio will offset losses from the drop in INmune Bio's long position.| Enliven Therapeutics vs. DiaMedica Therapeutics | Enliven Therapeutics vs. Lyra Therapeutics | Enliven Therapeutics vs. Centessa Pharmaceuticals PLC |
| INmune Bio vs. Tff Pharmaceuticals | INmune Bio vs. Anebulo Pharmaceuticals | INmune Bio vs. AN2 Therapeutics | INmune Bio vs. Cue Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |